Skip to main content
Signal8

Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses. The company's strategy involves researching, creating, and marketing innovative Selective Inhibitor of Nuclear Export (SINE) compounds, which operate by attaching to and deactivating the nuclear export protein XPO1. Their leading therapeutic, XPOVIO, holds approvals for several critical applications in adult patients: it is prescribed in combination with bortezomib and dexamethasone for multiple myeloma; alongside dexamethasone for those with heavily pretreated multiple myeloma; and as a standalone treatment for relapsed or refractory diffuse large B-cell lymphoma. Karyopharm has also established a licensing partnership with the Menarini Group, granting them rights to develop and market NEXPOVIO for human oncology indications across Europe (including the United Kingdom), Latin America, and other global regions. Furthermore, the company's oral SINE compounds are specifically engineered to promote the accumulation of various tumor suppressor and growth-regulating proteins within the cell nucleus. Established in 2008, Karyopharm Therapeutics Inc. maintains its principal offices in Newton, Massachusetts.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

OTC:KPTIOTC (suspended from Nasdaq on Nov 11, 2026)Sub-class of KPTIQHealthcare
Mkt Cap$395K
EV-
Float21.53M
O/S22.68M
VOL146.51M sh
$ Vol$5.23M
RVOL5.19×
Inst Own76.4%
SI38.2%
Net Cash/Sh-
Dilution
Karyopharm Therapeutics Inc. logoOTC:KPTI
Financials Summary
Revenue$146.07M
Net Income-$196.04M
Total Assets$108.42M
Free Cash Flow-$75.37M
Debt & Equity
Total Debt$233.61M
Total Equity-$292.93M
Shares Outstanding
Short Interest

No short interest data available.

Split History1 split · 1 reverse
2-year cumulative
1:15

Nasdaq bars a compliance period at 1:250

  1. 1:15Reverse split
    Feb 26, 202515 shares → 1
Balance Sheet Details
Assets$108.42M
Liabilities$401.34M
Accounts Receivable$26.18M
Accounts Payable$4M
Inventory$4.04M
PP&E (Net)$4.65M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$146.07M$145.24M$146.03M$157.07M$209.82M$108.08M$40.89M$30.34M$1.6M$154K$250K$229K$387K$634K$152K
YoY Growth0.6%-0.5%-7.0%-25.1%94.1%164.3%34.8%1790.1%942.2%-38.4%9.2%-40.8%-39.0%317.1%-
Cost of Revenue$5.95M$6.01M$4.94M$5.21M$3.4M$2.71M$2.41M$161.37M$107.27M$86.94M$97.74M$60.13M$28.45M$14.1M$0
Gross Profit$140.12M$139.23M$141.09M$151.86M$206.42M$105.38M$38.49M-$131.04M-$105.67M-$86.78M-$97.49M-$59.9M-$28.07M-$13.46M$152K
Gross Margin95.9%95.9%96.6%96.7%98.4%97.5%94.1%-431.9%-6583.7%-56353.2%-38997.6%-26156.3%-7251.9%-2123.2%100.0%
Research and Development$125.62M$143.23M$138.75M$148.66M$160.84M$150.81M$122.34M$161.37M$107.27M$86.94M$97.74M$60.13M$28.45M$14.1M$8.62M
Selling, General, and Administrative$105.21M$115.44M$131.88M$145.4M$143.85M$126.42M$105.42M$48.85M$24.87M$23.95M$21.58M$15.95M$5.88M$2.43M$1.84M
Other$0$0$0$0$0$0$0-$33K-$81K$10K-$2K-$27K$0$0$0
Total Operating Expenses$230.82M$258.67M$270.63M$294.06M$304.69M$277.23M$227.76M$210.22M$132.14M$110.89M$119.33M$76.08M$34.34M$16.52M$10.46M
Operating Income (EBIT)-$90.71M-$119.44M-$129.54M-$142.2M-$98.27M-$171.85M-$189.28M-$179.88M-$130.54M-$110.73M-$119.08M-$75.85M-$33.95M-$15.89M-$10.31M
Operating Margin-62.1%-82.2%-88.7%-90.5%-46.8%-159.0%-462.9%-593.0%-8133.2%-71903.9%-47630.4%-33120.5%-8772.6%-2506.3%-6783.6%
Interest Expense$45.85M$37.42M$23.82M$25M$26.05M$27.14M$15.65M$2.49M$0$0$0$1K$0$0$0
Interest Income$2.77M$7.4M$10.94M$2.36M$582K$2.82M$5.42M$4.03M$1.7M$1.28M$897K$97K$3K$2K$0
Other Income (Expense)-$105.29M$43.08M-$13.24M-$22.72M-$25.55M-$24.11M-$10.28M$1.5M$1.62M$1.29M$895K$69K$3K$2K$0
Income Before Tax (EBT)-$196M-$76.36M-$142.78M-$164.92M-$123.82M-$195.96M-$199.55M-$178.38M-$128.92M-$109.44M-$118.18M-$75.78M-$33.95M-$15.89M-$10.31M
Income Tax Expense$43K$57K$323K$369K$268K$309K$40K$26K$63K$139K-$895K-$69K-$3K-$2K$0
Net Income-$196.04M-$76.42M-$143.1M-$165.29M-$124.09M-$196.27M-$199.59M-$178.41M-$128.98M-$109.58M-$118.18M-$75.78M-$33.95M-$15.89M-$10.31M
Net Income Margin-134.2%-52.6%-98.0%-105.2%-59.1%-181.6%-488.1%-588.1%-8036.4%-71153.9%-47272.4%-33090.4%-8771.8%-2506.0%-6783.6%
Supplementary Data
EPS-17.93-9.41-18.79-30.28-24.75-40.87-48.32-47.11-42.15-43.80-49.80-36.45-83.85-8.01-5.20
Diluted EPS-17.93-9.41-18.79-30.28-24.75-40.87-48.32-47.11-42.15-43.80-49.80-36.45-83.85-8.01-5.20
Weighted Average OS10.94M8.12M7.61M5.46M5.01M4.80M4.13M3.79M3.06M2.50M2.37M2.08M404,511132,220132,220
EBITDA-$149.85M-$38.6M-$118.42M-$139.31M-$96.98M-$167.85M-$182.93M-$175.15M-$128.21M-$108.72M-$118.44M-$75.45M-$33.8M-$15.77M-$10.23M
EBITDA Margin-102.6%-26.6%-81.1%-88.7%-46.2%-155.3%-447.3%-577.4%-7988.0%-70598.1%-47376.8%-32949.3%-8734.6%-2486.8%-6728.9%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$60.54M$62.48M$52.23M$135.19M$190.46M$85.92M$128.86M$118.02M$69M$49.66M$58.36M$150.61M$155.97M$391K$6.51M
Short-Term Investments$3.2M$46.24M$139.21M$142.78M$38.16M$163.32M$133.1M$210.18M$77.47M$79.89M$117.28M$55.12M$0$0$0
Cash and Short-Term Investments$63.74M$108.71M$191.44M$277.97M$228.62M$249.24M$261.96M$328.2M$146.47M$129.55M$175.63M$205.72M$155.97M$391K$6.51M
Accounts Receivable$26.18M$30.77M$26.96M$47.09M$22.5M$12.88M$7.86M$0$0$0$0$0$0$0$0
Inventory$4.04M$4.74M$3.04M$4.22M$4.11M$2.64M$346K$0$0$0$0$0$0$0$0
Other Current Assets$9.19M$12.28M$12.47M$20.89M$6.35M$2.48M$1.12M$0$200K$0$0$0$0$0$0
Total Current Assets$103.15M$156.49M$233.92M$350.16M$275.61M$276.53M$278.57M$334.61M$148.42M$131.64M$177.6M$207.75M$157.96M$954K$6.87M
Long-Term Assets
Property, Plant & Equipment Net$4.65M$6.28M$4.88M$7.38M$9.56M$11.58M$13.66M$3.86M$2.19M$2.84M$3.48M$2.75M$240K$327K$328K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$351K$0$0$0$0$24.21M$2.02M$2M$29.4M$45.43M$33.88M$8.66M$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$267K$1.64M$1.64M$633K$20.14M$722K$714K$716K$290K$479K$482K$1.17M$30K$30K$30K
Total Long-Term Assets$5.27M$7.93M$6.52M$8.01M$29.7M$36.52M$16.39M$6.58M$31.87M$48.75M$37.84M$12.59M$270K$357K$358K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$108.42M$164.42M$240.44M$358.17M$305.31M$313.05M$294.96M$341.19M$180.29M$180.38M$215.44M$220.34M$158.23M$1.31M$7.22M
Liabilities
Current Liabilities
Accounts Payable$4M$5.11M$3.12M$2.77M$1.6M$4.45M$985K$4.33M$5.67M$4.75M$3.81M$6.29M$1.74M$1.08M$1.14M
Short-Term Debt$21.01M$24.43M$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$297K$2.34M$9.36M$21.92M$0$0$0$79K$66K$200K
Other Current Liabilities$5.96M$15.56M$18.16M$21.47M$20.36M$609K$500K$717K$436K$363K$301K$188K$305K$24K$16K
Total Current Liabilities$92.06M$92.26M$69.48M$65.91M$73.72M$60.2M$46.35M$46.9M$49.47M$16.48M$15.13M$12.3M$3.29M$1.93M$2.12M
Long-Term Liabilities
Long-Term Debt$205.88M$162.95M$170.92M$170.1M$169.29M$117.93M$109.86M$102.66M$0$0$0$0$0$0$0
Long-Term Unearned Revenue$72.34M$0$0$0$0$0$2.19M$4.53M$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$25.32M$88.51M$133.46M$132.72M$133M$73.09M$73.59M$3.92M$1.36M$1.67M$1.95M$1.24M$0$27.26M$17.76M
Total Long-Term Liabilities$309.28M$258.17M$307.17M$308.92M$311.26M$202.3M$198.84M$111.12M$1.36M$1.67M$1.95M$1.24M$0$27.26M$17.76M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$401.34M$350.44M$376.64M$374.83M$384.98M$262.5M$245.19M$158.02M$50.83M$18.14M$17.08M$13.54M$3.29M$29.19M$19.88M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$14K$13K$12K$12K$8K$7K$7K$6K$5K$4K$4K$3K$3K$0$0
Retained Earnings-$1.76B-$1.56B-$1.49B-$1.34B-$1.18B-$1.07B-$873.34M-$673.75M-$495.34M-$366.1M-$256.53M-$138.35M-$62.57M-$28.62M-$12.73M
Comprehensive Income & Other$71K-$356K-$161K-$638K$191K$518K-$37K-$244K-$217K-$274K-$282K-$29K$0$0$0
Other Stockholders' Equity$1.47B$1.38B$1.35B$1.33B$1.1B$1.12B$923.11M$856.91M$624.8M$528.34M$454.89M$345.14M$217.5M$745K$83K
Total Equity-$292.93M-$186.02M-$136.21M-$16.66M-$79.67M$50.55M$49.77M$183.17M$129.46M$162.24M$198.37M$206.79M$154.93M-$27.88M-$12.65M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$108.42M$164.42M$240.44M$358.17M$305.31M$313.05M$294.96M$341.19M$180.29M$180.38M$215.44M$220.34M$158.23M$1.31M$7.22M
Supplementary Data
Total Debt$233.61M$194.52M$177.02M$179.07M$180.58M$131.13M$124.7M$102.66M$0$0$0$0$0$0$0
Net Debt$173.07M$132.05M$124.78M$43.89M-$9.88M$45.21M-$4.15M-$15.36M-$69M-$49.66M-$58.36M-$150.61M-$155.97M-$391K-$6.51M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$196.04M-$76.42M-$143.1M-$165.29M-$124.09M-$196.27M-$199.59M-$178.41M-$128.98M-$109.58M-$118.18M-$75.78M-$33.95M-$15.89M-$10.31M
Depreciation & Amortization$296K$340K$530K$621K$789K$972K$974K$735K$713K$717K$634K$323K$144K$122K$83K
Deferred Income Tax$0$0$0$0$1.45M$904K-$1.38M$29K$0$0$1.78M$0$0$0$0
Stock-Based Compensation$14.05M$18.43M$21.71M$35.4M$29.78M$24.41M$15.29M$17.27M$20.41M$22.28M$17.06M$14.24M$3.79M$653K$24K
Changes in Working Capital:
  Accounts Receivable$4.59M-$3.8M$20.12M-$5.08M-$9.62M-$5.02M-$7.86M$0$0$0$0$0$0$0$0
  Inventory$701K-$1.7M$1.18M-$118K-$1.46M-$2.63M-$346K$0$0$0$0$0$0$0$0
  Accounts Payable-$1.1M$1.98M$350K$1.17M-$2.85M$3.46M-$3.3M-$1.38M$909K$945K-$2.43M$4.5M$664K-$66K$1.13M
  Other Working Capital$24.09M$3.21M$9.76M-$15.96M-$9.26M$5.54M-$1.8M$1.21M$32.05M$42K$6.42M$5.22M-$1.02M-$330K$524K
Total Working Capital Change$28.27M-$302K$31.41M-$19.99M-$23.19M$1.36M-$13.31M-$169K$32.96M$987K$4M$9.71M-$360K-$396K$1.66M
Other Non-Cash Items$78.05M-$69.53M-$3.28M-$294K$8.13M$8.4M$7.19M$1.42M$1.19M$1.2M$685K$52K$88K$257K$0
Net Cash from Operating-$75.37M-$127.49M-$92.72M-$149.55M-$107.12M-$160.23M-$190.82M-$159.12M-$73.72M-$84.39M-$94.03M-$51.45M-$30.29M-$15.51M-$8.55M
Investing Activities
Capital Expenditures$0-$142K$0-$118K-$5.71M-$145K-$206K-$2.36M-$62K-$70K-$1.42M-$2.83M-$57K-$121K-$376K
Acquisitions$0$0$0$104.26M$5.5M$53.54M-$78.66M$0$0$0$0$0$0$0$0
Purchases of Investments$0-$58.82M-$159.15M-$226.02M-$45.23M-$274.58M-$178.49M-$242.81M-$98.37M-$134.7M-$305.19M-$63.8M$0$0$0
Sales of Investments$43.38M$154.44M$167.09M$121.88M$192.78M$221.04M$257.14M$137.51M$115.54M$159.37M$215.87M$0$0$0$0
Other Investing Activities$0$0$0-$104.26M-$5.5M-$53.54M$78.66M-$105.3M$17.17M$24.66M-$82K-$400K$0$0$0
Net Cash from Investing$43.38M$95.47M$7.94M-$104.26M$141.84M-$53.69M$78.45M-$107.66M$17.11M$24.59M-$90.82M-$67.03M-$57K-$121K-$376K
Financing Activities
Debt Repaid-$20.54M-$83.3M---$60M---$166.88M-------
Common Stock Issuance$9.51M$1.45M$1.12M$189.76M$9.9M$161.78M$46.19M$145.71M$74.89M$50.57M$92.08M$112.84M$113.16M$9K$12K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0-$43.11M$0$3.98M$3.75M$10.31M$78.11M$3.52M$858K$591K$616K$284K$341K$0$0
Net Cash from Financing$30.05M$41.65M$1.12M$193.74M$73.65M$172.08M$124.31M$316.11M$75.74M$51.16M$92.7M$113.12M$185.93M$9.51M$11.99M
Forex Effect$20K-$11K-$34K-$488K-$48K$268K$19K-$78K$200K-$63K-$99K-$8K$0$0$0
Net Change in Cash-$1.92M$9.62M-$83.69M-$60.56M$108.32M-$41.57M$11.95M$49.25M$19.33M-$8.7M-$92.25M-$5.37M$155.58M-$6.12M$3.07M
Supplementary Data
Operating Cash Flow-$75.37M-$127.49M-$92.72M-$149.55M-$107.12M-$160.23M-$190.82M-$159.12M-$73.72M-$84.39M-$94.03M-$51.45M-$30.29M-$15.51M-$8.55M
Capital Expenditure$0-$142K$0-$118K-$5.71M-$145K-$206K-$2.36M-$62K-$70K-$1.42M-$2.83M-$57K-$121K-$376K
Free Cash Flow-$75.37M-$127.63M-$92.72M-$149.67M-$112.83M-$160.38M-$191.03M-$161.48M-$73.78M-$84.46M-$95.44M-$54.28M-$30.35M-$15.63M-$8.93M
Cash at Beginning$62.81M$53.19M$136.88M$197.44M$89.12M$130.69M$118.74M$69.49M$49.66M$58.36M$150.61M$155.97M$391K$6.51M$3.44M
Cash at End$60.89M$62.81M$53.19M$136.88M$197.44M$89.12M$130.69M$118.74M$69M$49.66M$58.36M$150.61M$155.97M$391K$6.51M